Early research (Phase 1)Study completedNCT00514306What this trial is testingStudy of Intermittent OSI-906 DosingWho this might be right forAdvanced Solid Tumors Astellas Pharma Inc 79
Early research (Phase 1)Ended earlyNCT04272034What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+15 more Incyte Corporation 105
Early research (Phase 1)Study completedNCT03849469What this trial is testingXmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsWho this might be right forMelanomaCervical CarcinomaPancreatic Carcinoma+20 more Xencor, Inc. 78
Testing effectiveness (Phase 2)Ended earlyNCT03024437What this trial is testingAtezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell CarcinomaWho this might be right forMetastatic CancerRenal Cancer Roberto Pili 31
Testing effectiveness (Phase 2)Looking for participantsNCT04198766What this trial is testingStudy of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)Who this might be right forSolid TumorNon-Small Cell Lung CancerHead and Neck Cancer+5 more Inhibrx Biosciences, Inc 340
Testing effectiveness (Phase 2)Study completedNCT03075423What this trial is testingRandomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCCWho this might be right forMetastatic Renal Cell Carcinoma Goethe University 316
Testing effectiveness (Phase 2)Ended earlyNCT01545817What this trial is testingEverolimus Post Pazopanib Treatment in Metastatic or Advanced Renal Cell CarcinomaWho this might be right forCarcinoma, Renal Cell Novartis Pharmaceuticals 74
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07277972What this trial is testingIparomlimab and Tuvonralimab Injection in Combination With Lenvatinib or Axitinib for the Treatment of Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma That Has Failed First-Line Systemic TherapyWho this might be right forRCC, Renal Cell Cancer Tianjin Medical University Cancer Institute and Hospital 36
Testing effectiveness (Phase 2)Study completedNCT01688973What this trial is testingTivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by SurgeryWho this might be right forRecurrent Renal Cell CarcinomaStage III Renal Cell CancerStage IV Renal Cell Cancer+2 more National Cancer Institute (NCI) 55
Early research (Phase 1)Active Not RecruitingNCT05653882What this trial is testingA Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid TumorsWho this might be right forSolid TumorNon Small Cell Lung CancerMelanoma+2 more Asher Biotherapeutics, Inc. 552
Testing effectiveness (Phase 2)Study completedNCT00848640What this trial is testingStudy of Sorafenib in Patients With Advanced Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell Carcinoma Egyptian Foundation For Cancer Research 75
Early research (Phase 1)Study completedNCT00623064What this trial is testingLapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter European Organisation for Research and Treatment of Cancer - EORTC 18
Early research (Phase 1)Ended earlyNCT06630247What this trial is testingA Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forSolid CancersSolid Tumor CancerSolid Tumor Malignancy+4 more Exelixis 9
Testing effectiveness (Phase 2)Study completedNCT02535533What this trial is testingSLM + Axitinib for Clear Cell RCCWho this might be right forAdvanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC) Mohammed Milhem 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT04022343What this trial is testingNeoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaRenal Cell CarcinomaStage III Renal Cell Cancer AJCC v8 Emory University 22
Not applicableStudy completedNCT04033991What this trial is testingStudy of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.Who this might be right forCarcinomaRenal Cell Pfizer 684
Testing effectiveness (Phase 2)Study completedNCT00354250What this trial is testingIspinesib in Treating Patients With Metastatic or Unresectable Kidney CancerWho this might be right forRecurrent Renal Cell CancerStage III Renal Cell CancerStage IV Renal Cell Cancer National Cancer Institute (NCI) 60
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Active Not RecruitingNCT03170960What this trial is testingStudy of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsWho this might be right forUrothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more Exelixis 914
Testing effectiveness (Phase 2)UnknownNCT01118039What this trial is testingSunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer Hospital del Mar 41